Cryo-Cell International, Inc. (CCEL)

NYSEAMERICAN: CCEL · IEX Real-Time Price · USD

7.72

-0.20 (-2.53%)

At close: Apr 23, 2024, 4:00 PM

8.12

+0.40 (5.18%)

Pre-market: Apr 24, 2024, 8:27 AM EDT

Cryo-Cell International Balance Sheet

Financials in millions USD. Fiscal year is December - November.

Millions USD. Fiscal year is Dec - Nov.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1995
Cash & Equivalents	0.41	1.7	8.26	10.36	6.54	6.04	6.28	3.5	4.36	3.48	Upgrade
Short-Term Investments	0.57	0.02	0.08	0.09	0.9	0.88	0.44	0.62	0.61	0.1	Upgrade
Cash & Cash Equivalents	0.98	1.72	8.34	10.45	7.45	6.92	6.72	4.12	4.97	3.59	Upgrade
Cash Growth	-43.06%	-79.35%	-20.20%	40.36%	7.65%	2.94%	62.91%	-16.97%	38.51%	-34.58%	Upgrade
Receivables	6.58	6.04	5.25	6.32	6.1	5.87	5.13	4.05	3.06	4.07	Upgrade
Inventory	6.03	10.13	10.62	11.99	13.73	16.04	0.31	0.36	0.48	0.06	Upgrade
Other Current Assets	-4.13	-8.28	-8.43	-10.21	-11.89	-14.06	0.58	0.47	1.85	0.77	Upgrade
Total Current Assets	9.45	9.61	15.78	18.56	15.39	14.76	12.74	9.01	10.35	8.49	Upgrade
Property, Plant & Equipment	22.03	14.21	4.15	1.94	1.85	1.49	0.88	0.98	0.88	0.95	Upgrade
Long-Term Investments	0.31	0.31	0.31	0.31	0.31	0.31	0	0	0	0.68	Upgrade
Goodwill and Intangibles	2.93	17.1	18.15	3.47	3.19	3.28	0.23	0.26	2.29	0.03	Upgrade
Other Long-Term Assets	26.5	23.66	22.27	21.92	22.15	22.55	10.06	9.29	5.97	0.05	Upgrade
Total Long-Term Assets	51.77	55.28	44.88	27.64	27.5	27.63	11.17	10.53	9.14	1.72	Upgrade
Total Assets	61.22	64.89	60.66	46.2	42.89	42.39	23.91	19.54	19.5	10.21	Upgrade
Accounts Payable	3.17	1.61	1.49	0.96	1.37	1.26	1.93	1.49	1.33	0.99	Upgrade
Deferred Revenue	50.89	45.59	40.63	36.38	32.51	28.68	23.18	19.67	17.65	16.17	Upgrade
Current Debt	1.61	2.72	2.21	3.38	3.1	3.1	2	2	0.31	0	Upgrade
Other Current Liabilities	-34.82	-30.43	-23.26	-24.3	-21.55	-17.61	-13.17	-10.04	-8.86	-8.04	Upgrade
Total Current Liabilities	20.86	19.48	21.07	16.41	15.43	15.43	13.94	13.11	10.42	9.13	Upgrade
Long-Term Debt	9.28	8.89	0.61	2.86	5.86	9.84	5.3	7.82	0.87	0	Upgrade
Other Long-Term Liabilities	42.11	38.04	34.79	29.59	28.55	26.03	17.18	14.02	13.17	11.81	Upgrade
Total Long-Term Liabilities	51.39	46.93	35.4	32.45	34.41	35.87	22.47	21.84	14.04	11.81	Upgrade
Total Liabilities	72.25	66.41	56.48	48.87	49.84	51.3	36.41	34.95	24.46	20.94	Upgrade
Total Debt	10.9	11.61	2.82	6.24	8.96	12.94	7.3	9.82	1.18	0	Upgrade
Debt Growth	-6.18%	311.68%	-54.79%	-30.32%	-30.81%	77.43%	-25.71%	734.75%	-	-	Upgrade
Retained Earnings	-31.16	-21.64	-16.74	-18.82	-22.44	-25.33	-24.47	-26.79	-25.47	-33.58	Upgrade
Comprehensive Income	0	0	0	0	0	0.34	0.04	0.03	0.17	0	Upgrade
Shareholders' Equity	-11.03	-1.52	4.18	-2.67	-6.95	-8.91	-12.5	-15.41	-4.96	-10.73	Upgrade
Net Cash / Debt	-9.92	-9.89	5.52	4.21	-1.51	-6.03	-0.58	-5.7	3.79	3.59	Upgrade
Net Cash / Debt Growth	-	-	31.08%	-	-	-	-	-	5.70%	-34.58%	Upgrade
Net Cash Per Share	-1.19	-1.17	0.66	0.52	-0.18	-0.81	-0.08	-0.70	0.39	0.34	Upgrade
Working Capital	-11.41	-9.87	-5.29	2.14	-0.04	-0.67	-1.2	-4.1	-0.07	-0.64	Upgrade
Book Value Per Share	-1.32	-0.18	0.51	-0.35	-0.89	-1.19	-1.77	-1.90	-0.52	-1.05	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).